GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Beijing Airdoc Technology Co Ltd (HKSE:02251) » Definitions » Debt-to-EBITDA

Beijing Airdoc Technology Co (HKSE:02251) Debt-to-EBITDA : -0.05 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Beijing Airdoc Technology Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Beijing Airdoc Technology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$9.4 Mil. Beijing Airdoc Technology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$0.8 Mil. Beijing Airdoc Technology Co's annualized EBITDA for the quarter that ended in Dec. 2023 was HK$-189.6 Mil. Beijing Airdoc Technology Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -0.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Beijing Airdoc Technology Co's Debt-to-EBITDA or its related term are showing as below:

HKSE:02251' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.08   Med: -0.05   Max: -0.01
Current: -0.08

During the past 5 years, the highest Debt-to-EBITDA Ratio of Beijing Airdoc Technology Co was -0.01. The lowest was -0.08. And the median was -0.05.

HKSE:02251's Debt-to-EBITDA is ranked worse than
100% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 2.63 vs HKSE:02251: -0.08

Beijing Airdoc Technology Co Debt-to-EBITDA Historical Data

The historical data trend for Beijing Airdoc Technology Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Airdoc Technology Co Debt-to-EBITDA Chart

Beijing Airdoc Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
-0.01 -0.01 -0.07 -0.05 -0.08

Beijing Airdoc Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only -0.04 -0.05 -0.06 -0.23 -0.05

Competitive Comparison of Beijing Airdoc Technology Co's Debt-to-EBITDA

For the Health Information Services subindustry, Beijing Airdoc Technology Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Airdoc Technology Co's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Beijing Airdoc Technology Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Beijing Airdoc Technology Co's Debt-to-EBITDA falls into.



Beijing Airdoc Technology Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Beijing Airdoc Technology Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(9.431 + 0.823) / -123.993
=-0.08

Beijing Airdoc Technology Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(9.431 + 0.823) / -189.558
=-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.


Beijing Airdoc Technology Co  (HKSE:02251) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Beijing Airdoc Technology Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Beijing Airdoc Technology Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Airdoc Technology Co (HKSE:02251) Business Description

Traded in Other Exchanges
N/A
Address
West Third Ring North Road, Room 21, 4th Floor, Building 2, A2 Yard, Haidian District, Beijing, CHN
Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices and other services.

Beijing Airdoc Technology Co (HKSE:02251) Headlines

No Headlines